JA
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
6.889
Exchange
XNAS - Nasdaq
70 %
Last period Net income growth rate
-134%
Net income growth rate has decreased in 5 years
What is Net income growth rate ?
An indicator of the company's profit growth rate relative to the same periods of previous years.
See also Jazz Pharmaceuticals
Company Analysis
JAZZ valuation, rating, competitors, insights and company profile
Eyestock Rating
JAZZ financial analysis by Eyestock methodology
Valuation
JAZZ valuation using historical relative method
Statements
JAZZ Income Statements, Balance Sheet and Cash Flow Statements
Dividends
JAZZ dividend yield and annual dividend
An indicator of the company's profit growth rate relative to the same periods of previous years.
Jazz Pharmaceuticals`s Net income growth rate for the period ended 2024-06-30 is 70 %
